The Searle Company Limited (PSX: SEARL) reported a 30.77% year-on-year increase in its consolidated profit for the first quarter ended September 30, 2026 (1QFY27), reaching Rs1.20bn compared to Rs914.15m in the same period last year.
Basic and diluted earnings per share (EPS) climbed 26.62% to Rs1.95 from a restated Rs1.54 in the corresponding quarter of FY26. The bottom-line growth was supported by higher revenue from contracts with customers, a stronger gross margin, and a sharp decline in tax levies, which offset rising distribution and administrative expenses.
| Financial Particulars (Rs.000) | 1QFY27 | 1QFY26 | Change (%) |
|---|---|---|---|
| Revenue from Contracts | 11,175,336 | 9,697,271 | +15.24% |
| Gross Profit | 6,396,068 | 5,244,301 | +21.96% |
| Profit from Operations | 2,230,103 | 1,823,165 | +22.32% |
| Profit for the Period | 1,195,475 | 914,152 | +30.77% |
| Earnings Per Share (EPS) | Rs1.95 | Rs1.54 | +26.62% |
Investor Takeaway: Strong top-line expansion and controlled cost of sales drove profitability higher despite higher operational and tax burdens, signalling solid operational resilience for Searle in the pharmaceutical sector.
Read the full story on the original publisher’s website.
Open original article